| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1040 |
| Trial ID | ChiCTR-OIC-17012251 |
| Disease | Chronic Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A phase I clinical trial of anti-CD19 CAR-T cell therapy for acute/chronic B lymphocytic leukemia |
| Year | 2017 |
| Country | China |
| Company sponsor | Gansu Provincial Hospital |
| Cohort 1 | |||||||
|
|||||||